MERCK SHARP DOHME branded and generic drugs, international patents

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Merck Sharp Dohme	ZINPLAVA	bezlotoxumab	INJECTABLE;INJECTION	761046	001	2016-10-21	9,181,632	MERCK SHARP & DOHME CORP. (Rahway, NJ)	➤ Sign Up	RX		search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	9,995,753		➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	9,994,550	3-V Biosciences, Inc. (Menlo Park, CA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	9,975,894	Plexxikon Inc. (Berkeley, CA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	9,968,606	NeuForm Pharmaceuticals, Inc. (Auburndale, MA)	➤ Sign Up	RX	Orphan	search
Merck Sharp Dohme	KEYTRUDA	pembrolizumab	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER	125514	001	2014-09-04	9,938,273	Plexxikon Inc. (Berkeley, CA)	➤ Sign Up	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

Merck Sharp Dohme Company Profile